BIBITEC GmbH is GMP-certified and specializes in the production of recombinant proteins and monoclonal antibodies for use in clinical trials up to phase III using mammalian cells.
The activities comprise the areas development and optimization of production processes, protein analytics,
formulation and quality assurance.
The fermentation capacity in mammalian cells is up to 100 L. Protein purification is located in clean rooms class C.
A five-year erythropoietin (EPO) project has already been completed. This project involved the process development,
the GMP-compliant production of EPO for use in phase III clinical tests and the establishment
of a production facility (Norbitec GmbH, Uetersen, Germany).
BIBITEC was founded in 2001 by Prof. Dr.-Ing. Jürgen Lehmann and other internationally recognized experts at the
University of Bielefeld, Germany, and since then has cooperated with various pharmaceutical and biotechnology companies.
Since 2012 BIBITEC is an affiliate of Nordmark Arzneimittel GmbH & Co. KG, Uetersen, Germany.